Investigation on chemotactic drug targeting (chemotaxis and adhesion) inducer effect of GnRH-III derivatives in Tetrahymena and human leukemia cell line

Eszter Lajkó, Ildikó Szabó, Katalin Andódy, András Pungor, G. Mező, L. Kőhidai

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

GnRH-III has been shown to exert a cytotoxic effect on the GnRH-R positive tumor cells. The chemotactic drug targeting (CDT) represents a new way for drug delivery approach based on selective chemoattractant guided targeting. The major goal of the present work was to develop and investigate various GnRH-III derivatives as potential targeting moieties for CDT. The cell physiological effects (chemotaxis, adhesion, and signaling) induced by three native GnRHs (hGnRH-I, cGnRH-II, and lGnRH-III) and nine GnRH-III derivatives were evaluated in two model cells (Tetrahymena pyriformis and Mono Mac 6 human monocytes). According to our results, the native GnRH-III elicited the highest chemoattractant and adhesion inducer activities of all synthesized peptides in micromolar concentrations in monocytes. With respect to chemoattraction, dimeric derivatives linked by a disulfide bridge ([GnRH-III(C)]2) proved to be efficient in both model cells; furthermore, acetylation of the linker region ([GnRH-III(Ac-C)]2) could slightly improve the chemotactic and adhesion effects in monocytes. The length of the peptide and the type of N-terminal amino acid could also determine the chemotactic and adhesion modulation potency of each fragment. The application of the chemoattractant GnRH-III derivatives was accompanied by a significant activation of phosphatidylinositol 3-kinase in both model cells. In summary, our work on low-level differentiated model cells of tumors has proved that GnRH-III and some of its synthetic derivatives are promising candidates to be applied in CDT: these compounds might act both as carrier, delivery unit, and antitumor agents.

Original languageEnglish
Pages (from-to)46-58
Number of pages13
JournalJournal of Peptide Science
Volume19
Issue number1
DOIs
Publication statusPublished - Jan 2013

Fingerprint

Tetrahymena
Chemotaxis
Drug Delivery Systems
Leukemia
Adhesion
Cells
Derivatives
Cell Line
Chemotactic Factors
Monocytes
Gonadotropin-Releasing Hormone
Tumors
Phosphatidylinositol 3-Kinase
Tetrahymena pyriformis
gonadotropin-releasing hormone-III
Acetylation
Peptides
Drug delivery
Disulfides
Antineoplastic Agents

Keywords

  • Adhesion
  • Chemotaxis
  • Dimer derivative
  • Drug targeting
  • Gonadotropin-releasing hormone III
  • Tetrahymena

ASJC Scopus subject areas

  • Structural Biology
  • Molecular Medicine
  • Molecular Biology
  • Biochemistry
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this

Investigation on chemotactic drug targeting (chemotaxis and adhesion) inducer effect of GnRH-III derivatives in Tetrahymena and human leukemia cell line. / Lajkó, Eszter; Szabó, Ildikó; Andódy, Katalin; Pungor, András; Mező, G.; Kőhidai, L.

In: Journal of Peptide Science, Vol. 19, No. 1, 01.2013, p. 46-58.

Research output: Contribution to journalArticle

@article{0d4250e8e5c34770a9d6d9eb8f621366,
title = "Investigation on chemotactic drug targeting (chemotaxis and adhesion) inducer effect of GnRH-III derivatives in Tetrahymena and human leukemia cell line",
abstract = "GnRH-III has been shown to exert a cytotoxic effect on the GnRH-R positive tumor cells. The chemotactic drug targeting (CDT) represents a new way for drug delivery approach based on selective chemoattractant guided targeting. The major goal of the present work was to develop and investigate various GnRH-III derivatives as potential targeting moieties for CDT. The cell physiological effects (chemotaxis, adhesion, and signaling) induced by three native GnRHs (hGnRH-I, cGnRH-II, and lGnRH-III) and nine GnRH-III derivatives were evaluated in two model cells (Tetrahymena pyriformis and Mono Mac 6 human monocytes). According to our results, the native GnRH-III elicited the highest chemoattractant and adhesion inducer activities of all synthesized peptides in micromolar concentrations in monocytes. With respect to chemoattraction, dimeric derivatives linked by a disulfide bridge ([GnRH-III(C)]2) proved to be efficient in both model cells; furthermore, acetylation of the linker region ([GnRH-III(Ac-C)]2) could slightly improve the chemotactic and adhesion effects in monocytes. The length of the peptide and the type of N-terminal amino acid could also determine the chemotactic and adhesion modulation potency of each fragment. The application of the chemoattractant GnRH-III derivatives was accompanied by a significant activation of phosphatidylinositol 3-kinase in both model cells. In summary, our work on low-level differentiated model cells of tumors has proved that GnRH-III and some of its synthetic derivatives are promising candidates to be applied in CDT: these compounds might act both as carrier, delivery unit, and antitumor agents.",
keywords = "Adhesion, Chemotaxis, Dimer derivative, Drug targeting, Gonadotropin-releasing hormone III, Tetrahymena",
author = "Eszter Lajk{\'o} and Ildik{\'o} Szab{\'o} and Katalin And{\'o}dy and Andr{\'a}s Pungor and G. Mező and L. Kőhidai",
year = "2013",
month = "1",
doi = "10.1002/psc.2472",
language = "English",
volume = "19",
pages = "46--58",
journal = "Journal of Peptide Science",
issn = "1075-2617",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Investigation on chemotactic drug targeting (chemotaxis and adhesion) inducer effect of GnRH-III derivatives in Tetrahymena and human leukemia cell line

AU - Lajkó, Eszter

AU - Szabó, Ildikó

AU - Andódy, Katalin

AU - Pungor, András

AU - Mező, G.

AU - Kőhidai, L.

PY - 2013/1

Y1 - 2013/1

N2 - GnRH-III has been shown to exert a cytotoxic effect on the GnRH-R positive tumor cells. The chemotactic drug targeting (CDT) represents a new way for drug delivery approach based on selective chemoattractant guided targeting. The major goal of the present work was to develop and investigate various GnRH-III derivatives as potential targeting moieties for CDT. The cell physiological effects (chemotaxis, adhesion, and signaling) induced by three native GnRHs (hGnRH-I, cGnRH-II, and lGnRH-III) and nine GnRH-III derivatives were evaluated in two model cells (Tetrahymena pyriformis and Mono Mac 6 human monocytes). According to our results, the native GnRH-III elicited the highest chemoattractant and adhesion inducer activities of all synthesized peptides in micromolar concentrations in monocytes. With respect to chemoattraction, dimeric derivatives linked by a disulfide bridge ([GnRH-III(C)]2) proved to be efficient in both model cells; furthermore, acetylation of the linker region ([GnRH-III(Ac-C)]2) could slightly improve the chemotactic and adhesion effects in monocytes. The length of the peptide and the type of N-terminal amino acid could also determine the chemotactic and adhesion modulation potency of each fragment. The application of the chemoattractant GnRH-III derivatives was accompanied by a significant activation of phosphatidylinositol 3-kinase in both model cells. In summary, our work on low-level differentiated model cells of tumors has proved that GnRH-III and some of its synthetic derivatives are promising candidates to be applied in CDT: these compounds might act both as carrier, delivery unit, and antitumor agents.

AB - GnRH-III has been shown to exert a cytotoxic effect on the GnRH-R positive tumor cells. The chemotactic drug targeting (CDT) represents a new way for drug delivery approach based on selective chemoattractant guided targeting. The major goal of the present work was to develop and investigate various GnRH-III derivatives as potential targeting moieties for CDT. The cell physiological effects (chemotaxis, adhesion, and signaling) induced by three native GnRHs (hGnRH-I, cGnRH-II, and lGnRH-III) and nine GnRH-III derivatives were evaluated in two model cells (Tetrahymena pyriformis and Mono Mac 6 human monocytes). According to our results, the native GnRH-III elicited the highest chemoattractant and adhesion inducer activities of all synthesized peptides in micromolar concentrations in monocytes. With respect to chemoattraction, dimeric derivatives linked by a disulfide bridge ([GnRH-III(C)]2) proved to be efficient in both model cells; furthermore, acetylation of the linker region ([GnRH-III(Ac-C)]2) could slightly improve the chemotactic and adhesion effects in monocytes. The length of the peptide and the type of N-terminal amino acid could also determine the chemotactic and adhesion modulation potency of each fragment. The application of the chemoattractant GnRH-III derivatives was accompanied by a significant activation of phosphatidylinositol 3-kinase in both model cells. In summary, our work on low-level differentiated model cells of tumors has proved that GnRH-III and some of its synthetic derivatives are promising candidates to be applied in CDT: these compounds might act both as carrier, delivery unit, and antitumor agents.

KW - Adhesion

KW - Chemotaxis

KW - Dimer derivative

KW - Drug targeting

KW - Gonadotropin-releasing hormone III

KW - Tetrahymena

UR - http://www.scopus.com/inward/record.url?scp=84871661145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871661145&partnerID=8YFLogxK

U2 - 10.1002/psc.2472

DO - 10.1002/psc.2472

M3 - Article

VL - 19

SP - 46

EP - 58

JO - Journal of Peptide Science

JF - Journal of Peptide Science

SN - 1075-2617

IS - 1

ER -